Spotlight Innovation Inc., which has licensed a therapeutic through Indiana University Research and Technology Corp. that could treat Spinal Muscular Atrophy, has created a Scientific Advisory Board that includes the Indiana University School of Medicine researcher who discovered and developed the therapeutic.
Dr. Elliot J. Androphy, Chair of the Department of Dermatology, has been named to the Board. He is the author of 135 journal articles published in Science, Nature, EMBO Molecular Medicine, Human Molecular Genetics, Journal of Virology, Molecular Cell, and other publications.
Other board members include Kevin Hodgetts of Brigham and Women’s Hospital and Harvard Medical School and Hengli Tang of Florida State University.
“We’re honored that these eminent inventors, scientists and key opinion leaders have chosen to serve on our SAB,” said Dr. Geoffrey Laff, Spotlight Innovation’s Senior Vice President of Business Development. “Their ongoing technical and strategic guidance will influence our allocation of resources and accelerate development of our early-stage pipeline product candidates.”
Leave a Reply